Cargando…
Systemically identifying and prioritizing risk lncRNAs through integration of pan-cancer phenotype associations
LncRNAs have emerged as a major class of regulatory molecules involved in normal cellular physiology and disease, our knowledge of lncRNAs is very limited and it has become a major research challenge in discovering novel disease-related lncRNAs in cancers. Based on the assumption that diverse diseas...
Autores principales: | Xu, Chaohan, Qi, Rui, Ping, Yanyan, Li, Jie, Zhao, Hongying, Wang, Li, Du, Michael Yifei, Xiao, Yun, Li, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355324/ https://www.ncbi.nlm.nih.gov/pubmed/28076842 http://dx.doi.org/10.18632/oncotarget.14510 |
Ejemplares similares
-
LncNetP, a systematical lncRNA prioritization approach based on ceRNA and disease phenotype association assumptions
por: Xu, Chaohan, et al.
Publicado: (2017) -
Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers
por: Li, Yongsheng, et al.
Publicado: (2020) -
PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers
por: Ali, Mohamad Moustafa, et al.
Publicado: (2018) -
Global Prioritizing Disease Candidate lncRNAs via a Multi-level Composite Network
por: Yao, Qianlan, et al.
Publicado: (2017) -
A pan‐cancer atlas of cancer hallmark‐associated candidate driver lncRNAs
por: Deng, Yulan, et al.
Publicado: (2018)